Favourites   Have ideas?  Sign in / Register

Positive:   Blood ↓10.77   Surgery ↓10.38   Biology ↓6.93 «See more»   Disease: Central nervous system (CNS) ↑1.55   Disease: Neurology/Alzheimer/Parkinson's ↑2.6   T cell-based ↑2.67

Negative:   Bad infrastructure  0.00


Immunology segment

ACRS Aclaris Therapeutics, Inc. - Common Stock -11.23% -11.23% 0 + Immunology, Biopharma, Medicine


Last highlighted: #ACRS SEC report: Aclaris Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Aclaris Therapeutics, Inc. -- SEC File Number
+ My List
ADTX ADiTx Therapeutics, Inc. - Common Stock 0 + Immunology, RNA, Medicine

+ My List
AFMD Affimed N.V. - Common Stock 1.45% down 9.2% -7.75 + Immunology, Cancer fight, Medicine

+ My List
AGEN Agenus Inc. - Common Stock 8.79% 8.79% 0 + Cancer fight, Immunology, Medicine


Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities
+ My List
AKER Akers Biosciences Inc. - Common Stock 0.00% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ALDX Aldeyra Therapeutics, Inc. - Common Stock 0.00% 0 + Immunology, Medicine

+ My List
ALEC Alector, Inc. - Common Stock 6.26% down 11.73% -5.47 + Disease: Neurology/Alzheimer/Parkinson's, Immunology, Medicine


Last highlighted: #ALEC SEC report: Alector, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Alector, Inc. -- SEC File Number
+ My List
ALT Altimmune, Inc. - Common Stock -3.21% down 13.98% -17.19 + Immunology, Biopharma, Medicine


Last highlighted: #ALT SEC report: Altimmune, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Altimmune, Inc. -- SEC File Number
+ My List
ANAB AnaptysBio, Inc. - Common Stock 8.41% 8.41% 0 + Immunology, Cancer fight, Medicine

+ My List
ANIX Anixa Biosciences, Inc. - Common Stock 4.62% up -14.7% 19.32 + Cancer fight, Medicine, Immunology

+ My List
APVO Aptevo Therapeutics Inc. - Common Stock 1.26% down 9.83% -8.57 + Biotechnology, Medicine, Disease: Oncology, Immunology


Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab
+ My List
ARGX argenx SE - American Depositary Shares 0.64% 0.64% 0 + Immunology, Medicine

+ My List
ASLN ASLAN Pharmaceuticals Limited - American Depositary Shares 0 + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine


Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq
+ My List
ATHX Athersys, Inc. - Common Stock up -7.92% 7.92 + Medicine, Immunology, Gene and cell, Disease: Cardiovascular, Disease: Neurology/Alzheimer/Parkinson's

+ My List
AUPH Aurinia Pharmaceuticals Inc - Common Shares down 8.85% -8.85 + Pharmaceutical , Immunology, Country: Canada


Last highlighted: FORM 10-Q [Quarterly Report] recently SEC filed. $AUPH #AuriniaPharmaceuticals Inc. Aurinia Pharmaceuticals Inc https://t.co/ei2FxR7sZR
+ My List
AVCO Avalon GloboCare Corp. - Common Stock 0 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
BLCM Bellicum Pharmaceuticals, Inc. - Common Stock 1.82% up -12.6% 14.42 + Biopharma, Medicine, Immunology


Last highlighted: #BLCM SEC report: BELLICUM PHARMACEUTICALS, INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by BELLICUM PHARMACEUTICALS, INC -- SEC File Number
+ My List
BNTX BioNTech SE - American Depositary Shares -8.35% -8.35% 0 + Biotechnology, Immunology, Covid (fighting), Medicine


Last highlighted: #BNTX SEC report: BioNTech SE Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BioNTech SE -- SEC File Number 211142358
+ My List
BTAI BioXcel Therapeutics, Inc. - Common Stock 0.37% down 12.65% -12.28 + Medicine, Immunology, Artificial Intelligence, Biopharma

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares -10.07% -10.07% 0 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CABA Cabaletta Bio, Inc. - Common Stock -7.92% -7.92% 0 + Gene and cell, Medicine, Immunology

+ My List
CCXI ChemoCentryx, Inc. - Common Stock -4.42% down 8.51% -12.93 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CLDX Celldex Therapeutics, Inc. - Common Stock 9.51% 9.51% 0 + Cancer fight, Immunology, Medicine


Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052
+ My List
CRVS Corvus Pharmaceuticals, Inc. - Common Stock down 10.48% -10.48 + Medicine, Immunology, Pharmaceutical

+ My List
CTSO Cytosorbents Corporation - Common Stock -10.38% -10.38% 0 + Immunology, Medicine, Surgery


Last highlighted: #CTSO SEC report: Cytosorbents Corp Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Cytosorbents Corp -- SEC File Number 211074173
+ My List
CUE Cue Biopharma, Inc. - Common Stock -9.67% -9.67% 0 + Biopharma, Immunology, Cancer fight

+ My List
DBVT DBV Technologies S.A. - American Depositary Shares 0.42% down 7.66% -7.24 + Immunology, Biopharma, Medicine


Last highlighted: #DBVT SEC report: DBV Technologies S.A. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by DBV Technologies S.A. -- SEC File Number 211136660
+ My List
DVAX Dynavax Technologies Corporation - Common Stock -0.48% up -7.27% 6.79 + Immunology, Biology, Biopharma, Medicine, Vaccines


Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number
+ My List
EDSA Edesa Biotech, Inc. - Common Shares -1.75% up -8.33% 6.58 + Medicine, Biopharma, Immunology

+ My List
ENOB Enochian Biosciences, Inc. - Common Stock -11.11% -11.11% 0 + Disease: Infectious, Cancer fight, Immunology, Medicine

+ My List
FATE Fate Therapeutics, Inc. - Common Stock 3.72% down 9.1% -5.38 + Cancer fight, Immunology, Medicine

+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock 5.52% down 8.21% -2.69 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GNCA Genocea Biosciences, Inc. - Common Stock 0 + Cancer fight, Immunology, Medicine

+ My List
GRTS Gritstone Oncology, Inc. - Common Stock 5.58% down 7.17% -1.59 + Medicine, Immunology, Cancer fight

+ My List
HGEN Humanigen, Inc. - Common Stock 6.88% down 7.25% -0.37 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock 3.14% down 9.8% -6.66 + Disease: Infectious, Immunology, Cancer fight, Medicine

+ My List
HTGM HTG Molecular Diagnostics, Inc. - Common Stock 0 + Immunology, Medicine


Last highlighted: #HTGM SEC report: HTG MOLECULAR DIAGNOSTICS, INC Statement of changes in beneficial ownership of securities
+ My List
IMNM Immunome, Inc. - Common Stock -4.15% up -8.39% 4.24 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMTX Immatics N.V. - Ordinary Shares up -7.67% 7.67 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IMV IMV Inc. - Common Shares up -12.62% 12.62 + Immunology, Medicine, Country: Canada, Covid (fighting), Biopharma


Last highlighted: #IMV SEC report: IMV Inc. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by IMV Inc. -- SEC File Number 211138178
+ My List
IMVT Immunovant, Inc. - Common Stock 2.88% 2.88% 0 + Medicine, Immunology


Last highlighted: #IMVT SEC report: Immunovant, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Immunovant, Inc. -- SEC File Number
+ My List
INMB INmune Bio Inc. - Common stock 0.74% down 8.3% -7.56 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock 5.34% down 8.23% -2.89 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock -6.71% -6.71% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
JNCE Jounce Therapeutics, Inc. - Common Stock -9.64% -9.64% 0 + Immunology, Cancer fight, Medicine

+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock 0 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KZR Kezar Life Sciences, Inc. - Common Stock 4.31% down 8.62% -4.31 + Immunology, Medicine

+ My List
MDNA Medicenna Therapeutics Corp. - Common Shares 8.26% 8.26% 0 + Country: Canada, Immunology


Last highlighted: #MDNA SEC report: Medicenna Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Medicenna Therapeutics Corp. -- SEC File Number 211089394
+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock -10.77% -10.77% 0 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MOR MorphoSys AG - American Depositary Shares 2.12% down 9.5% -7.38 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MRKR Marker Therapeutics, Inc. - Common Stock 0 + Immunology, Medicine, Cancer fight


Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01
+ My List
NK NantKwest, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Immunology
- Bad infrastructure
+ My List
NLTX Neoleukin Therapeutics, Inc. - Common Stock -8.33% -8.33% 0 + Medicine, Immunology


Last highlighted: #NLTX SEC report: Neoleukin Therapeutics, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Neoleukin Therapeutics, Inc. -- SEC File Number 211148247
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock 5.85% down 10.17% -4.32 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
ONCR Oncorus, Inc. - Common Stock 5.71% up -11.88% 17.59 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ONCS OncoSec Medical Incorporated - Common Stock 0 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ONCY Oncolytics Biotech Inc. - Common Shares 7.77% 7.77% 0 + Medicine, Cancer fight, Country: Canada, Immunology


Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8
+ My List
PAND Pandion Therapeutics Inc. - Common stock 0.00% 0 + Immunology, Medicine, Organ transplants


Last highlighted: SEC Form 8-K [Press/News Current Report] filed by $PAND #PandionTherapeutics, Inc https://t.co/uNtZ9rhD94
+ My List
PDSB PDS Biotechnology Corporation - Common Stock -7.61% -7.61% 0 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PHIO Phio Pharmaceuticals Corp. - Common Stock 0 + Medicine, Cancer fight, Immunology


Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock 1.18% down 7.05% -5.87 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PRVB Provention Bio, Inc. - Common Stock 4.71% 4.71% 0 + Immunology, Medicine


Last highlighted: #PRVB SEC report: Provention Bio, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Provention Bio, Inc. -- SEC File Number
+ My List
QDEL Quidel Corporation - Common Stock 2.00% 2.00% 0 + Medicine, Disease: Infectious, Immunology


Last highlighted: $QDEL 8-K Quidel (22 Apr, 4:53pm) 📰 Quidel Announces Preliminary Revenue for First Quarter 2021 https://t.co/LsfiDmSNca #QDEL #8K #Quidel #News
+ My List
SELB Selecta Biosciences, Inc. - Common Stock -4.96% down 8.59% -13.55 + Biotechnology, Immunology, Biology, Medicine


Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS
+ My List
SURF Surface Oncology, Inc. - Common Stock down 14.57% -14.57 + Cancer fight, Immunology, Medicine


Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938
+ My List
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock 1.55% down 11.8% -10.25 + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)


Last highlighted: $TNXP TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure https://t.co/hFCRf3OmpX
+ My List
TRIL Trillium Therapeutics Inc. - Common Shares 0.00% 0 + Country: Canada, Cancer fight, Disease: Oncology, Immunology


Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number
+ My List
VIR Vir Biotechnology, Inc. - Common Stock -3.58% -3.58% 0 + Immunology, Medicine


Last highlighted: #VIR SEC report: Vir Biotechnology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Vir Biotechnology, Inc. -- SEC File Number 211148349
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock 0 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 8.03% 8.03% 0 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -10.61% -10.61% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
EVAX Evaxion Biotech A/S - American Depositary Share -15.34% -15.34% 0 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FSTX F-star Therapeutics, Inc. - Common Stock 11.8% 11.8% 0 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GTBP GT Biopharma, Inc. - Common Stock 16.03% 16.03% 0 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
NEXI NexImmune, Inc. - Common Stock -9.33% -9.33% 0 + Medicine, Immunology


Last highlighted: A Form 10-Q [Quarterly Report] filing has been made with the SEC: $NEXI #NexImmune, Inc. #NexImmune, Inc https://t.co/SsyxY2SUAE
+ My List
PRTG Portage Biotech Inc. - Common Stock -8.8% -8.8% 0 + Country: Canada, Immunology, Cancer fight, Disease: Oncology

+ My List
RXDX Prometheus Biosciences, Inc. - Common Stock -6.42% up -7.04% 0.62 + Biotechnology, Medicine, Diagnosing, Immunology

+ My List
SCPS Scopus BioPharma Inc. - Common Stock 0 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.